Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

The New Zealand Neuromuscular Disease Patient Registry; Five Years and a Thousand Patients.

Rodrigues MJ, O'Grady GL, Hammond-Tooke G, Kidd A, Love DO, Baker RK, Roxburgh RH.

J Neuromuscul Dis. 2017;4(3):183-188. doi: 10.3233/JND-170240.

2.

Interpreting Musculoskeletal Models and Dynamic Simulations: Causes and Effects of Differences Between Models.

Roelker SA, Caruthers EJ, Baker RK, Pelz NC, Chaudhari AMW, Siston RA.

Ann Biomed Eng. 2017 Nov;45(11):2635-2647. doi: 10.1007/s10439-017-1894-5. Epub 2017 Aug 4.

PMID:
28779473
3.

The Role of ARX in Human Pancreatic Endocrine Specification.

Gage BK, Asadi A, Baker RK, Webber TD, Wang R, Itoh M, Hayashi M, Miyata R, Akashi T, Kieffer TJ.

PLoS One. 2015 Dec 3;10(12):e0144100. doi: 10.1371/journal.pone.0144100. eCollection 2015.

4.

FGF21-Mediated Improvements in Glucose Clearance Require Uncoupling Protein 1.

Kwon MM, O'Dwyer SM, Baker RK, Covey SD, Kieffer TJ.

Cell Rep. 2015 Nov 24;13(8):1521-7. doi: 10.1016/j.celrep.2015.10.021. Epub 2015 Nov 12.

5.

Overexpression of PAX4 reduces glucagon expression in differentiating hESCs.

Gage BK, Baker RK, Kieffer TJ.

Islets. 2014;6(2):e29236. doi: 10.4161/isl.29236.

6.

Overexpression of PPARγ specifically in pancreatic β-cells exacerbates obesity-induced glucose intolerance, reduces β-cell mass, and alters islet lipid metabolism in male mice.

Hogh KL, Craig MN, Uy CE, Nygren H, Asadi A, Speck M, Fraser JD, Rudecki AP, Baker RK, Orešič M, Gray SL.

Endocrinology. 2014 Oct;155(10):3843-52. doi: 10.1210/en.2014-1076. Epub 2014 Jul 22.

PMID:
25051434
7.

Infants' ability to associate motion paths with object kinds.

Baker RK, Pettigrew TL, Poulin-Dubois D.

Infant Behav Dev. 2014 Feb;37(1):119-29. doi: 10.1016/j.infbeh.2013.12.005. Epub 2014 Jan 31.

PMID:
24486789
8.

IGFBP2 is neither sufficient nor necessary for the physiological actions of leptin on glucose homeostasis in male ob/ob mice.

Neumann UH, Chen S, Tam YY, Baker RK, Covey SD, Cullis PR, Kieffer TJ.

Endocrinology. 2014 Mar;155(3):716-25. doi: 10.1210/en.2013-1622. Epub 2014 Jan 1.

PMID:
24424049
9.

Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the US.

Buchacz K, Baker RK, Palella FJ Jr, Shaw L, Patel P, Lichtenstein KA, Chmiel JS, Vellozzi C, Debes R, Henry K, Overton ET, Bush TJ, Tedaldi E, Carpenter C, Mayer KH, Brooks JT; HIV Outpatient Study Investigators.

Antivir Ther. 2013;18(1):65-75. doi: 10.3851/IMP2450. Epub 2012 Oct 30.

PMID:
23111762
10.

Overexpression of peroxisome proliferator-activated receptor α in pancreatic β-cells improves glucose tolerance in diet-induced obese mice.

Hogh KL, Uy CE, Asadi A, Baker RK, Riedel MJ, Gray SL.

Exp Physiol. 2013 Feb;98(2):564-75. doi: 10.1113/expphysiol.2012.068734. Epub 2012 Oct 5.

11.

CD4 Cell Counts at HIV Diagnosis among HIV Outpatient Study Participants, 2000-2009.

Buchacz K, Armon C, Palella FJ, Baker RK, Tedaldi E, Durham MD, Brooks JT.

AIDS Res Treat. 2012;2012:869841. doi: 10.1155/2012/869841. Epub 2011 Sep 20.

12.

Increased mortality among publicly insured participants in the HIV Outpatient Study despite HAART treatment.

Palella FJ Jr, Baker RK, Buchacz K, Chmiel JS, Tedaldi EM, Novak RM, Durham MD, Brooks JT; HOPS Investigators.

AIDS. 2011 Sep 24;25(15):1865-76. doi: 10.1097/QAD.0b013e32834b3537.

PMID:
21811144
13.

In their own words: why teenagers don't use social networking sites.

Baker RK, White KM.

Cyberpsychol Behav Soc Netw. 2011 Jun;14(6):395-8. doi: 10.1089/cyber.2010.0016. Epub 2010 Nov 30.

PMID:
21117974
14.

Identification of RING finger protein 4 (RNF4) as a modulator of DNA demethylation through a functional genomics screen.

Hu XV, Rodrigues TM, Tao H, Baker RK, Miraglia L, Orth AP, Lyons GE, Schultz PG, Wu X.

Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15087-92. doi: 10.1073/pnas.1009025107. Epub 2010 Aug 9.

15.

Cellular reprogramming of human amniotic fluid cells to express insulin.

Gage BK, Riedel MJ, Karanu F, Rezania A, Fujita Y, Webber TD, Baker RK, Wideman RD, Kieffer TJ.

Differentiation. 2010 Sep-Oct;80(2-3):130-9. doi: 10.1016/j.diff.2010.05.007. Epub 2010 Jun 19.

PMID:
20561745
16.

AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study.

Buchacz K, Baker RK, Palella FJ Jr, Chmiel JS, Lichtenstein KA, Novak RM, Wood KC, Brooks JT; HOPS Investigators.

AIDS. 2010 Jun 19;24(10):1549-59. doi: 10.1097/QAD.0b013e32833a3967.

PMID:
20502317
17.

Expression of beta 2 integrin (CD18) in embryonic mouse and chicken heart.

Oliveira LA, Baker RK, Klewer SE, Kitten GT.

Braz J Med Biol Res. 2010 Jan;43(1):25-35. doi: 10.1590/S0100-879X2010000100005.

18.

Changes in the use of HIV antiretroviral resistance testing in a large cohort of U.S. patients, 1999 to 2006.

Buchacz K, Baker RK, Young B, Brooks JT; HIV Outpatient Study (HOPS) Investigators.

J Acquir Immune Defic Syndr. 2010 Apr;53(5):625-32. doi: 10.1097/QAI.0b013e3181bf1dd2.

PMID:
19841587
19.

Attention deficit hyperactivity disorder and increased risk of injury.

Merrill RM, Lyon JL, Baker RK, Gren LH.

Adv Med Sci. 2009;54(1):20-6. doi: 10.2478/v10039-009-0022-7.

PMID:
19586835
20.

Healthcare claims for identifying the level of diagnostic investigation and treatment of cancer.

Merrill RM, Baker RK, Lyon JL, Gren LH.

Med Sci Monit. 2009 May;15(5):PH25-31.

PMID:
19396046
21.

Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994-2005.

Buchacz K, Baker RK, Moorman AC, Richardson JT, Wood KC, Holmberg SD, Brooks JT; HIV Outpatient Study (HOPS) Investigators.

AIDS. 2008 Jul 11;22(11):1345-54. doi: 10.1097/QAD.0b013e328304b38b.

PMID:
18580614
22.

Renal function in Tenofovir-exposed and Tenofovir-unexposed patients receiving highly active antiretroviral therapy in the HIV Outpatient Study.

Young B, Buchacz K, Baker RK, Moorman AC, Wood KC, Chmiel J, Brooks JT; HIV Outpatient Study Investigators.

J Int Assoc Physicians AIDS Care (Chic). 2007 Sep;6(3):178-87. Epub 2007 Jun 19.

PMID:
17579126
23.

Psychological disorders among children and the parents of children undergoing cancer workup.

Merrill RM, Brown RJ, Alder S, Baker RK, Byrd AD, White GL Jr, Lyon JL.

J Psychosoc Oncol. 2007;25(3):1-18. doi: 10.1300/J077v25n03_01.

PMID:
19341011
24.

Renal function in patients receiving tenofovir with ritonavir/lopinavir or ritonavir/atazanavir in the HIV Outpatient Study (HOPS) cohort.

Buchacz K, Young B, Baker RK, Moorman A, Chmiel JS, Wood KC, Brooks JT.

J Acquir Immune Defic Syndr. 2006 Dec 15;43(5):626-8. No abstract available.

PMID:
17133215
25.

Evaluation of hypophosphataemia in tenofovir disoproxil fumarate (TDF)-exposed and TDF-unexposed HIV-infected out-patients receiving highly active antiretroviral therapy.

Buchacz K, Brooks JT, Tong T, Moorman AC, Baker RK, Holmberg SD, Greenberg A; HIV Outpatient Study (HOPS) Investigators.

HIV Med. 2006 Oct;7(7):451-6.

26.

Increased body mass index does not alter response to initial highly active antiretroviral therapy in HIV-1-infected patients.

Tedaldi EM, Brooks JT, Weidle PJ, Richardson JT, Baker RK, Buchacz K, Moorman AC, Wood KC, Holmberg SD; HOPS Investigators.

J Acquir Immune Defic Syndr. 2006 Sep;43(1):35-41.

PMID:
16885779
27.

Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

Palella FJ Jr, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, Holmberg SD; HIV Outpatient Study Investigators.

J Acquir Immune Defic Syndr. 2006 Sep;43(1):27-34.

PMID:
16878047
28.

The changing spectrum of pulmonary disease in patients with HIV infection on antiretroviral therapy.

Grubb JR, Moorman AC, Baker RK, Masur H.

AIDS. 2006 May 12;20(8):1095-107. Review. No abstract available.

PMID:
16691060
29.

Short-term safety and tolerability of didanosine combined with high- versus low-dose tenofovir disproxil fumarate in ambulatory HIV-1-infected persons.

Young B, Weidle PJ, Baker RK, Armon C, Wood KC, Moorman AC, Holmberg SD; HIV Outpatient Study (HOPS) Investigators.

AIDS Patient Care STDS. 2006 Apr;20(4):238-44.

PMID:
16623622
30.

Potent Kv1.3 inhibitors from correolide-modification of the C18 position.

Bao J, Miao S, Kayser F, Kotliar AJ, Baker RK, Doss GA, Felix JP, Bugianesi RM, Slaughter RS, Kaczorowski GJ, Garcia ML, Ha SN, Castonguay L, Koo GC, Shah K, Springer MS, Staruch MJ, Parsons WH, Rupprecht KM.

Bioorg Med Chem Lett. 2005 Jan 17;15(2):447-51.

PMID:
15603971
31.

Anatomic characteristics of ruptured abdominal aortic aneurysm on conventional CT scans: Implications for rupture risk.

Fillinger MF, Racusin J, Baker RK, Cronenwett JL, Teutelink A, Schermerhorn ML, Zwolak RM, Powell RJ, Walsh DB, Rzucidlo EM.

J Vasc Surg. 2004 Jun;39(6):1243-52.

32.

Hepatitis A and B vaccination practices for ambulatory patients infected with HIV.

Tedaldi EM, Baker RK, Moorman AC, Wood KC, Fuhrer J, McCabe RE, Holmberg SD; HIV Outpatient Study (HOPS) Investigators.

Clin Infect Dis. 2004 May 15;38(10):1478-84. Epub 2004 Apr 28.

PMID:
15156488
33.

Regulation of Hex gene expression and initial stages of avian hepatogenesis by Bmp and Fgf signaling.

Zhang W, Yatskievych TA, Baker RK, Antin PB.

Dev Biol. 2004 Apr 15;268(2):312-26.

34.

Ephs and ephrins during early stages of chick embryogenesis.

Baker RK, Antin PB.

Dev Dyn. 2003 Sep;228(1):128-42.

35.

Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy.

Tedaldi EM, Baker RK, Moorman AC, Alzola CF, Furhrer J, McCabe RE, Wood KC, Holmberg SD; HIV Outpatient Study (HOPS) Investigators.

Clin Infect Dis. 2003 Feb 1;36(3):363-7. Epub 2003 Jan 14.

PMID:
12539079
36.

Prevalence and clinical correlates of HIV viremia ('blips') in patients with previous suppression below the limits of quantification.

Sklar PA, Ward DJ, Baker RK, Wood KC, Gafoor Z, Alzola CF, Moorman AC, Holmberg SD; HIV Outpatient Study (HOPS) Investigators.

AIDS. 2002 Oct 18;16(15):2035-41.

PMID:
12370502
37.

Novel fragmentation reaction of correolide.

Bao J, Baker RK, Doss GA, Kayser F, Kotliar A, Miao S, Parsons WH, Rupprecht KM.

Org Lett. 2002 May 30;4(11):1871-3.

PMID:
12027635
38.

Catalytic inhibition of human DNA topoisomerase IIalpha by hypericin, a naphthodianthrone from St. John's wort (Hypericum perforatum).

Peebles KA, Baker RK, Kurz EU, Schneider BJ, Kroll DJ.

Biochem Pharmacol. 2001 Oct 15;62(8):1059-70.

PMID:
11597574
39.

Benzene metabolites antagonize etoposide-stabilized cleavable complexes of DNA topoisomerase IIalpha.

Baker RK, Kurz EU, Pyatt DW, Irons RD, Kroll DJ.

Blood. 2001 Aug 1;98(3):830-3.

40.

Expression of the receptor tyrosine kinase gene EphB3 during early stages of chick embryo development.

Baker RK, Vanderboom AK, Bell GW, Antin PB.

Mech Dev. 2001 Jun;104(1-2):129-32.

41.

Potential metabolic interaction between St. John's wort and theophylline.

Nebel A, Schneider BJ, Baker RK, Kroll DJ.

Ann Pharmacother. 1999 Apr;33(4):502. No abstract available.

PMID:
10332544
42.

Infants' expectations about object label reference.

Graham SA, Baker RK, Poulin-Dubois D.

Can J Exp Psychol. 1998 Sep;52(3):103-13.

PMID:
9849097
43.

A novel cardiac-restricted target for doxorubicin. CARP, a nuclear modulator of gene expression in cardiac progenitor cells and cardiomyocytes.

Jeyaseelan R, Poizat C, Baker RK, Abdishoo S, Isterabadi LB, Lyons GE, Kedes L.

J Biol Chem. 1997 Sep 5;272(36):22800-8.

44.

In vitro preselection of gene-trapped embryonic stem cell clones for characterizing novel developmentally regulated genes in the mouse.

Baker RK, Haendel MA, Swanson BJ, Shambaugh JC, Micales BK, Lyons GE.

Dev Biol. 1997 May 15;185(2):201-14.

45.

Embryonic stem cells and in vitro muscle development.

Baker RK, Lyons GE.

Curr Top Dev Biol. 1996;33:263-79. Review. No abstract available.

PMID:
9138907
46.

Positive and negative control of the Antennapedia promoter P2.

Riley GR, Jorgensen EM, Baker RK, Garber RL.

Dev Suppl. 1991;1:177-85.

PMID:
1683801
47.
48.

Purification and characterization of hen oviduct microsomal signal peptidase.

Baker RK, Lively MO.

Biochemistry. 1987 Dec 29;26(26):8561-7.

PMID:
2831945
49.
50.

Partial purification of microsomal signal peptidase from hen oviduct.

Baker RK, Bentivoglio GP, Lively MO.

J Cell Biochem. 1986;32(3):193-200.

PMID:
3536973

Supplemental Content

Loading ...
Support Center